Stock Analysis

Edenred (ENXTPA:EDEN): Exploring Valuation Following New WonderDays Partnership and B2B Expansion Moves

Edenred (ENXTPA:EDEN) has just unveiled a fresh partnership with WonderDays, utilizing its payment solutions expertise to support and scale WonderDays’ gift card platform. This move could help extend Edenred’s reach within B2B, B2C, and the employee rewards markets.

See our latest analysis for Edenred.

Edenred’s headline partnership comes during a tough stretch for the stock, with a 1-year total shareholder return of -24.4% and the share price sliding 34.7% year-to-date. Short-term pressures seem to have weighed on sentiment, but over the longer term, recent strategic moves suggest underlying growth ambitions, even as momentum remains subdued compared to prior years.

If Edenred’s latest collaboration has you looking beyond the obvious, it might be the perfect moment to discover fast growing stocks with high insider ownership.

But with shares trading well below analyst targets despite consistent revenue and profit growth, the real question is whether Edenred now represents an undervalued opportunity or if the market is already considering its future growth potential.

Advertisement

Most Popular Narrative: 41.6% Undervalued

According to the most widely followed narrative, Edenred's fair value calculation comes in well above the recent closing price. The stage is set for significant upside, but it hinges on future growth and the payoff of recent partnerships.

Robust expansion in Latin America and Asia through organic growth and targeted acquisitions (for example, Spirii in Denmark, RB in Brazil, and IP Plus in Italy) is diversifying revenue streams, reducing exposure to sluggish European markets, and supporting top-line growth even in uncertain environments.

Read the complete narrative.

Curious what’s fueling this ambitious valuation? The narrative’s forecast builds on game-changing expansion strategies and bold profit margin moves. The full financial playbook shaping Edenred’s future price sits just one click away.

Result: Fair Value of €34.85 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent regulatory pressures and slower growth in key European markets could easily derail Edenred’s anticipated recovery and long-term trajectory.

Find out about the key risks to this Edenred narrative.

Build Your Own Edenred Narrative

If you see the story differently or want to dig deeper into the numbers yourself, it takes just minutes to craft your own narrative. Do it your way.

A great starting point for your Edenred research is our analysis highlighting 4 key rewards and 4 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Opportunities rarely wait. Expand your portfolio by acting on these standout investment angles available exclusively with Simply Wall Street’s powerful Screener tools:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Edenred might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com